Modulation of antioxidant defenses during apoptosis

Oncology Research

Volumn 9, Issue 6-7, 1997, Pages 281-285

  Briehl, Margaret M ^a   Baker, Amanda F ^a   Siemankowski, Linda M ^a   Morreale, Jeanne ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Antioxidant defense; Apoptosis; Glucocorticoid; Oxidative stress; Tumor necrosis factor

Indexed keywords

ANTIOXIDANT;

ANIMAL; APOPTOSIS; CYTOLOGY; HUMAN; MALE; MOUSE; PHYSIOLOGY; PROSTATE; REVIEW;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; HUMANS; MALE; MICE; PROSTATE;

EID: 0031297872     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Kerr, J. F. R.; Wyllie, A. H.; Currie, A. R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26:239-257; 1972.
2. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462; 1995.
3. Briehl, M. M. Apoptosis: New ideas in pathology. In: Weinstein, R. S.; Graham, A. R., eds. Advances in pathology and laboratory medicine, vol. 9. Chicago: Mosby-Year Book, Inc.; 1996:431-450.
4. Miesfeld, R. L. The structure and function of steroid receptor proteins. Crit. Rev. Biochem. Mol. Biol. 24:101-117; 1989.
5. Briehl, M. M.; Miesfeld, R. L. Isolation and characterization of transcripts induced by androgen withdrawal and apoptotic cell death in the rat ventral prostate. Mol. Endocrinol. 5:1381-1388; 1991.
6. Bettuzzi, S.; Hiipakka, R. A.; Gilna, P.; Lio, S. Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis. Biochem. J. 257:293-296; 1989.
7. Chang, C.; Saltzman, A. G.; Sorensen, N. S.; Hiipakka, R. A.; Liao, S. Identification of glutatione S-transferase Yb, mRNA as the androgen-repressed mRNA by cDNA cloning and sequence analysis. J. Biol. Chem. 262:11901-11903; 1987.
8. Danielsen, M.; Stallcup, M. R. Down-regulation of glucocorlicoid receptors in mouse lymphoma cell variants. Mol. Cell. Biol. 4:449-453; 1984.
9. Briehl, M. M.; Cotgreave, I. A.; Powis, G. Downregulation of the antioxidant defence during glucocorticoid-mediated apoptosis. Cell Death Differ. 2:41-46; 1995.
10. Flomerfelt, F. A.; Briehl, M. M.; Dowd, D. R.; Dicken, E. S.; Miesfeld, R. L. Elevated glutathione S-tranferase gene expression is an early event during steroid-induced lymphocyte apoptosis. J. Cell. Physiol. 154:573-581; 1993.
11. Mannervik, B.; Danielson, U. H. Glutathione transferases structure and catalytic activity. CRC Crit. Rev. Biochem. 23: 283-337; 1988.
12. Pickett, C. B.; Lu, A. Y. H. Glutathione S-transferases: Gene structure, regulation and biological function. Annu. Rev. Biochem. 58:743-764; 1989.
13. Berhane, K.; Widersten, M.; Engstrom, A.; Kozarich, J. W.; Mannervik, B. Detoxification of base propenals and other (7,6-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc. Natl. Acad. Sci. USA 91:1480-1484; 1994.
14. Forman, H. J.; Fisher, A. B. Antioxidant defenses. In: Gilbert, D. L., ed. Oxygen and living processes. New York: Springer-Verlag; 1981:235-249.
15. Powis, G.; Briehl, M. M.; Oblong, J. Redox signalling and the control of cell growth and death. Pharmacol. Ther. 68: 149-173; 1995.
16. Baker, A. F.; Briehl, M. M.; Dorr, R.; Powis, G. Decreased antioxidant defence and increased oxidant stress during dexamethasone-induced apoptosis: bcl-2 prevents the loss of antioxidant enzyme activity. Cell Death Differ. 3:207-213; 1996.
17. Tsujimoto, Y.; Cossman, J.; Jaffe, E.; Croce, C. M. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440-1443; 1985.
18. Vaux, D. L.; Cory, S.; Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442; 1988.
19. Nunez, G.; London, L.; Hockenbery, D.; Alexander, M.; McKearn, J. P.; Korsmeyer, S. J. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol. 144:3602-3610; 1990.
20. Reed, J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1-6; 1994.
21. Lam, M.; Dubyak, G.; Chen, L.; Nunez, G.; Miesfeld, R. L.; Distelhorst, C. W. Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2 fluxes. Proc. Natl. Acad. Sci. USA 91:6569-6573; 1994.
22. Hockenbery, D. M.; Oltvai, Z. N.; Yin, X-M.; Miiliman, C. L.; Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251; 1993.
23. Kane, D. J.; Sarafian, T. A.; Anton, R.; Hahn, H.; Gralla, E. B.; Valentine, J. S.; Ord, T.; Bredesen, D. E. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 262:1274-1277; 1993.
24. Shimizu, S.; Eguchi, Y.; Kosaka, H.; Kamiike, W.; Matsuda, H.; Tsujimoto, Y. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374:811-813; 1995.
25. Jacobson, M. D.; Raff, M. C. Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374:814-816; 1995.
26. Powis, G.; Gasdaska, J. R.; Gasdaska, P. Y.; Berggren, M.; Kirkpatrick, D. L.; Engman, L.; Cotgreave, I. A.; Angulo, M.; Baker, A. Selenium and the thioredoxin redox system: Effects on cell growth and death. Oncol. Res. 9:303-312; 1997.
27. Larrick, J. W.; Wright, S. C. Cytotoxic mechanism of tumor necrosis factor-a. FASEB J. 4:3215-3223; 1990.
28. Semenzato, G. Tumour necrosis factor: A cytokine with multiple biological activities. Br. J. Cancer 61:354-361 ; 1990.
29. Sugarmann, B. J.; Aggarwal, B. B.; Mass, P. E.; Figari, I. S.; Palladino, M. A., Jr.; Shepard, H. M. Recombinant human tumor necrosis factor-a: Effects on proliferation of normal transformed cells in vitro. Science 230:943-945; 1985.
30. Laster, S. M.; Wood, J. G.; Gooding, L. R. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J. Immunol. 141:2629-2634; 1988.
31. Wiegmann, K.; Schütze, S.; Kämpen, E.; Himmler, A.; Machleidt, T.; Kronke, M. Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J. Biol. Chem. 267:17997-18001; 1992.
32. Smith, C. A.; Farrah, T.; Goodwin, R. G. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959-962; 1994.
33. Hsu, H.; Shu, H.-B.; Pan, M.-G.; Goeddel, D. V. TRADDTRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299-308;1996.
34. Boldin, M. P.; Goncharov, T. M.; Goltsev, Y. V.; Wallach, D. Involvement of MACH, a novel MORT1/FADDinteracting protease, in Fas/APO-1-and TNF receptorinduced cell death. Cell 85:803-815; 1990.
35. Matthews, N.; Neale, M. L.; Jackson, S. K.; Stark, J. M. Tumour cell killing by tumour necrosis factor: Inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism. Immunology 62:153-155; 1987.
36. Zimmerman, R. J.; Chan, A.; Leadon, S. A. Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor. Cancer Res. 49:1644-1648; 1989.
37. Yamauchi, N.; Kuriyama, H.; Watanabe, N.; Neda, H.; Maeda, M.; Niitsu, Y. Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro. Cancer Res. 49:1671-1675; 1989.
38. Hennet, T.; Richter, C.; Peterhans, E. Tumour necrosis factor-a induces Superoxide anion generation in mitochondria of L929 cells. Biochem. J. 289:587-592; 1993.
39. Wong, G. H. W.; Goeddel, D. V. Induction of manganous Superoxide dismutatse by tumor necrosis factor: Possible protective mechanism. Science 242:941-944; 1988.
40. Wong, G. H. W.; Elwell, J. H.; Oberley, L. W.; Goeddel, D. V. Manganous Superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58: 923-931; 1989.
41. Buttke, T. M.; Sandstrom, P. A. Oxidative stress as a mediator of apoptosis. Immunol. Today 15:7-10; 1994.
42. Beg, A. A.; Baltimore, D. An essential role for NF-icB in preventing TNF-a-induced cell death. Science 274:782-784; 1996.
43. Wang, C-Y.; Mayo, M. W.; Baldwin, A. S., Jr. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-xB. Science 274:784-787; 1996.
44. Van Antwerp, D. J. V.; Martin, S. J.; Kafri, T.; Green, D. R.; Verma, I. M. Suppression of TNF-a-induced apoptosis by NF-B. Science 274:787-789; 1996.